Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Tolerion Inc.
DescriptionPlasmid encoding the extracellular domain of nicotinic acetylcholine receptor (nAchR) alpha 1
Molecular Target Nicotinic acetylcholine receptor (nAchR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationMyasthenia gravis
Indication DetailsTreat myasthenia gravis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today